-
Business
-
Policy & Business
-
-
Federal IT
-
Information Technology
-
-
State & Local
-
State & Local Government
-
-
Defense
-
Defense & Intelligence
-
-
Healthcare
-
Healthcare Policy & IT
-
-
Energy
-
Energy Policy & Technology
-
-
Education
-
Education Policy & Technology
-
FDA outlines policy for overseeing nanotechnology
AZ Central: WASHINGTON (AP) -- Federal regulators want to hear from companies using tiny, engineered micro-particles in their products, part of an effort to stay abreast of the growing field of nanotechnology.
The Food and Drug Administration issued final recommendations Tuesday for companies using nanotechnology in products regulated by the government, which can include medical therapies, food and cosmetics. FDA regulators want companies to consult with them before launching nanotechnology products, though the decision whether to go to market will essentially rest with manufacturers.
Tags
Share
Top Stories
- Lacking statewide vaccine plan, Florida counties turn to Eventbrite
- CIOs and CTOs look to cloud for infrastructure modernization
- Health IT execs offer thoughts on the big issues of 2021
- Emotet Malware Returns with 100K Daily Emails, New Evasion Tactics
- OCR issues guidance on disclosure of protected info using health information exchanges
- What healthcare orgs should be doing in response to the SolarWinds breach
- Inside Amazon's efforts to build a national telehealth business geared toward big employers
- Telehealth poses big cybersecurity dangers, Harvard researchers warn
- Third-Party Vendor Dental Care Alliance Breach Impacts 1M Patients
- At one urban health center, ‘regulatory change was critical’ to telehealth success
- What's next for cybersecurity in 2021? Ransomware-as-a-service, DDoS and more
- Montana Hospital Group to Pay $4.2M After Breach Lawsuit
- Bipartisan Cadre of Lawmakers Call for Permanent Telehealth Expansion
- As vaccine rollout looms, so do big questions around supply chains
- Hackers taking aim at crucial COVID-19 vaccine 'cold chain,' says IBM
- GIS data will be critical for successful vaccine distribution
Whitepapers & Special Reports
i360Gov Newsletters
The most significant government policy, business, and technology news and analysis delivered to your inbox.
Subscribe NowAlso in Healthcare Policy & IT
About
i360Gov is an intelligent network of websites and e-newsletters that provides government business, policy and technology leaders with a single destination for the most important news and analysis regarding their agency strategies and initiatives.
Contact Us
Telephone: 202.760.2280
Toll Free: 855.i360.Gov
Fax: 202.697.5045
Newsletters
Copyright © 2009-2025 i360Communications, LLC.